BioPharma2 years ago
First Wave BioPharma (NASDAQ:FWBI) on Track to Release Top-Line Data in July for Digestive Disorder in Cystic Fibrosis
First Wave BioPharma, Inc. (NASDAQ:FWBI) shares rocket 169% as the company announced the enrollment target for its ongoing Phase 2 SPAN clinical trial has been achieved. ...